AMTB

N/A

Report date: 2025/03/18 14:36:40
NME

Base Information

Drug NameAMTB
Drug Alias NameAMTB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 antagonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsUrinary Bladder, OveractiveCystitis, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveCystitis, Interstitial

Other Information

ATC CodeN/A
Related LinksN/A